Akero Therapeutics (AKRO) Misses Q3 EPS by 1c
Akero Therapeutics (NASDAQ: AKRO) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.
Akero Therapeutics (NASDAQ: AKRO) reported Q3 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.